Purpose Despite having a generally favorable prognosis, differentiated thyroid cancer is
known to have a significant, long-term impact on the quality of life of survivors. We wished to …

Background Adjuvant treatment with radioactive iodine (RAI) is often considered in the
treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of …

Objective Determine the prevalence of sialadenitis in a group of patients treated with
radioactive iodine (RAI) for well-differentiated thyroid cancer and assess whether RAI …

Background Although many studies focus on short‐term side effects of radioiodine therapy,
almost none studied long‐term side effects. We assessed radioiodine long‐term salivary …

Background Remnant radioiodine ablation is discouraged in low-risk differentiated thyroid
cancer because it confers no survival advantage. The impact of remnant radioiodine …

Background: Understanding of changes in salivary and lacrimal gland functions after
radioactive iodine therapy (131I-therapy) remains limited, and, to date, no studies have …

The long-term dental safety profile of high-dose radioiodine therapy remained elusive
despite more than 6 decades of clinical use. Methods: In a cohort study, we investigated the …

Background Postoperative radioactive iodine (RAI) administration is widely utilized in
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …

Radioactive iodine therapy (RAIT) is one of the important treatment modalities in the
management of differentiated thyroid cancer (DTC). RAIT with iodine-131 has long been …

Introduction Thyroid cancer survivors are a rapidly growing population in the United States.
The factors that drive health-related quality of life (HRQOL) in this population have not been …